Brief: Heidelberg Pharma Requests Mandatory Conversion Of Notes Issued Nov 2017
Oct 25 (Reuters) - HEIDELBERG PHARMA AG WL6G.DE :
* REQUESTING MANDATORY CONVERSION OF NOTES ISSUED IN BEARER
FORM
("NOTES") ON 22 NOVEMBER 2017
* CONVERSION PRICE FOR MANDATORY CONVERSION HAS BEEN
DETERMINED TO
BE EUR 2.60
* A TOTAL OF 14,968,380 NOTES WITH A NOMINAL VALUE OF EUR
1.00
EACH WERE ISSUED
* 134,184 NOTES HAD NOT BEEN CONVERTED INTO SHARES AS OF 25
OCTOBER 2019.
* WITH MANDATORY CONVERSION OF 134,184 OUTSTANDING NOTES, UP
TO
51,609 NEW SHARES WILL BE CREATED
Source text for Eikon: ID:nEQ6GmFCxa
Further company coverage: WL6G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty